• By Dana Sparks

Strategic Relationship on Genome Diagnostics

January 22, 2013

Mayo Clinic and Silicon Valley Biosystems (SV Bio) are announcing a strategic collaboration for whole genome diagnostics and interpretation at the Mayo Clinic Center for Individualized Medicine and Mayo Medical Laboratories. This strategic collaboration unites SV Bio’s proprietary genome interpretation solution with Mayo Clinic’s growing genome reference library and its commitment to individualized medicine, and will increase accessibility and clinical utility of next-generation sequencing for patients.

Click here for news release

Please login or become a member to post a comment.